| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.649 | 0.012 | 0.649 | Aryl hydrocarbon receptor agonist | 0.161 0.128 CID_114981 | ||
| 0.625 | 0.005 | 0.625 | GABA C receptor rho-3 antagonist | 0.395 0.064 CID_114981 | ||
| 0.581 | 0.005 | 0.581 | Peroxidase inhibitor | 0.511 0.009 CID_114981 | ||
| 0.561 | 0.013 | 0.561 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.473 0.047 CID_114981 | ||
| 0.524 | 0.005 | 0.524 | Interleukin 2 agonist | |||
| 0.492 | 0.034 | 0.492 | Aldehyde oxidase inhibitor | 0.177 0.118 CID_114981 | ||
| 0.464 | 0.025 | 0.464 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.472 | 0.04 | 0.472 | Calcium channel L-type activator | |||
| 0.46 | 0.034 | 0.46 | 5 Hydroxytryptamine release stimulant | 0.178 0.142 CID_114981 | ||
| 0.439 | 0.02 | 0.439 | Superoxide dismutase inhibitor | 0.209 0.107 CID_114981 | ||
| 0.432 | 0.017 | 0.432 | Sigma receptor agonist | |||
| 0.43 | 0.022 | 0.43 | Dyrk kinase inhibitor | |||
| 0.428 | 0.021 | 0.428 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.443 | 0.053 | 0.443 | Histamine release inhibitor | |||
| 0.433 | 0.059 | 0.433 | 5 Hydroxytryptamine release inhibitor | 0.302 0.163 CID_114981 | ||
| 0.369 | 0.005 | 0.369 | Telomerase inhibitor | |||
| 0.442 | 0.088 | 0.442 | Caspase 9 stimulant | 0.408 0.106 CID_114981 | ||
| 0.355 | 0.009 | 0.355 | Interleukin 6 antagonist | |||
| 0.345 | 0.01 | 0.345 | Neurotrophic factor enhancer | 0.171 0.109 CID_114981 | ||
| 0.37 | 0.035 | 0.37 | DNA damaging | 0.19 0.124 CID_114981 | ||
| 0.342 | 0.007 | 0.342 | GABA C receptor agonist | 0.16 0.03 CID_114981 | ||
| 0.348 | 0.03 | 0.348 | Interleukin agonist | |||
| 0.32 | 0.005 | 0.32 | MAP kinase kinase 3 inhibitor | |||
| 0.32 | 0.017 | 0.32 | LIM domain kinase 1 inhibitor | |||
| 0.333 | 0.031 | 0.333 | 5 Hydroxytryptamine uptake stimulant | 0.222 0.114 CID_114981 | ||
| 0.324 | 0.023 | 0.324 | Tyrosine 3 hydroxylase inhibitor | 0.311 0.028 CID_114981 | ||
| 0.35 | 0.05 | 0.35 | Calcium channel activator | 0.236 0.164 CID_114981 | ||
| 0.316 | 0.019 | 0.316 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.222 0.057 CID_114981 | ||
| 0.299 | 0.008 | 0.299 | Carbonic anhydrase XV inhibitor | 0.099 0.068 CID_114981 | ||
| 0.374 | 0.086 | 0.374 | 15-Lipoxygenase inhibitor | |||
| 0.28 | 0.007 | 0.28 | GABA C receptor rho-2 antagonist | 0.154 0.068 CID_114981 | ||
| 0.285 | 0.012 | 0.285 | Hexokinase inhibitor | 0.128 0.106 CID_114981 | ||
| 0.39 | 0.118 | 0.39 | Apoptosis agonist | |||
| 0.317 | 0.047 | 0.317 | Transcription factor STAT inhibitor | 0.262 0.079 CID_114981 | ||
| 0.279 | 0.01 | 0.279 | Ferrochelatase inhibitor | 0.16 0.034 CID_114981 | ||
| 0.305 | 0.037 | 0.305 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.306 | 0.041 | 0.306 | DNA synthesis inhibitor | |||
| 0.277 | 0.016 | 0.277 | Toll-Like receptor 9 antagonist | |||
| 0.315 | 0.054 | 0.315 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.297 | 0.039 | 0.297 | Clk dual-specificity kinase inhibitor | |||
| 0.262 | 0.004 | 0.262 | HIV-1 integrase (Overall Integration) inhibitor | 0.112 0.045 CID_114981 | ||
| 0.306 | 0.051 | 0.306 | Transcription factor STAT3 inhibitor | |||
| 0.293 | 0.038 | 0.293 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.262 | 0.015 | 0.262 | DNA intercalator | |||
| 0.286 | 0.04 | 0.286 | MAP kinase kinase 2 inhibitor | |||
| 0.25 | 0.006 | 0.25 | GABA C receptor antagonist | 0.175 0.019 CID_114981 | ||
| 0.285 | 0.042 | 0.285 | Death-associated protein kinase 3 inhibitor | |||
| 0.263 | 0.022 | 0.263 | Histone acetyltransferase inhibitor | |||
| 0.263 | 0.022 | 0.263 | Heat shock protein 90 alpha antagonist | 0.207 0.045 CID_114981 | ||
| 0.324 | 0.085 | 0.324 | Transcription factor NF kappa B inhibitor | |||
| 0.253 | 0.015 | 0.253 | Cystathionine beta-synthase inhibitor | 0.131 0.05 CID_114981 | ||
| 0.252 | 0.015 | 0.252 | 5 Hydroxytryptamine 3E antagonist | 0.196 0.069 CID_114981 | ||
| 0.296 | 0.061 | 0.296 | Insulysin inhibitor | 0.291 0.064 CID_114981 | ||
| 0.238 | 0.005 | 0.238 | GABA C receptor rho-1 antagonist | 0.107 0.053 CID_114981 | ||
| 0.255 | 0.022 | 0.255 | Alpha-N-acetylglucosaminidase inhibitor | 0.191 0.037 CID_114981 | ||
| 0.308 | 0.075 | 0.308 | 12-Lipoxygenase inhibitor | 0.2 0.152 CID_114981 | ||
| 0.251 | 0.02 | 0.251 | Heat shock protein 90 antagonist | 0.172 0.054 CID_114981 | ||
| 0.248 | 0.019 | 0.248 | Interleukin 1 antagonist | |||
| 0.242 | 0.013 | 0.242 | Interleukin 1b antagonist | |||
| 0.237 | 0.008 | 0.237 | Protein kinase C zeta inhibitor | |||
| 0.287 | 0.059 | 0.341 | Tumour necrosis factor alpha release inhibitor | 0.341 0.04 CID_114981 | CID_114981 | |
| 0.268 | 0.04 | 0.268 | RNA-directed DNA polymerase inhibitor | |||
| 0.32 | 0.093 | 0.32 | Prostaglandin dehydrogenase inhibitor | |||
| 0.23 | 0.008 | 0.23 | MAP3K9 inhibitor | 0.162 0.044 CID_114981 | ||
| 0.226 | 0.004 | 0.226 | Glutamate release inhibitor | 0.094 0.054 CID_114981 | ||
| 0.23 | 0.008 | 0.23 | 5 Hydroxytryptamine 3A agonist | 0.094 0.083 CID_114981 | ||
| 0.252 | 0.033 | 0.252 | Lipocortins synthesis antagonist | 0.135 0.13 CID_114981 | ||
| 0.25 | 0.032 | 0.25 | Nitric-oxide synthase stimulant | 0.172 0.147 CID_114981 | ||
| 0.23 | 0.012 | 0.23 | Ca(v)2.2 blocker | |||
| 0.272 | 0.054 | 0.272 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.241 | 0.025 | 0.241 | Succinate dehydrogenase inhibitor | 0.193 0.055 CID_114981 | ||
| 0.236 | 0.022 | 0.236 | CDC-like kinase 1 inhibitor | |||
| 0.263 | 0.053 | 0.263 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.253 | 0.044 | 0.253 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.226 | 0.018 | 0.226 | Catenin beta inhibitor | 0.162 0.079 CID_114981 | ||
| 0.266 | 0.058 | 0.266 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.225 | 0.019 | 0.225 | Mannose-6-phosphate isomerase inhibitor | 0.159 0.057 CID_114981 | ||
| 0.244 | 0.041 | 0.244 | I kappa B kinase epsilon inhibitor | |||
| 0.242 | 0.039 | 0.242 | Mcl-1 antagonist | |||
| 0.25 | 0.05 | 0.25 | Anesthetic general | |||
| 0.237 | 0.037 | 0.237 | Protein kinase C nu inhibitor | |||
| 0.246 | 0.047 | 0.246 | CDC-like kinase 4 inhibitor | |||
| 0.203 | 0.005 | 0.203 | NMDA 2C receptor antagonist | |||
| 0.29 | 0.096 | 0.29 | Vasodilator, coronary | |||
| 0.237 | 0.044 | 0.237 | Focal adhesion kinase 2 inhibitor | 0.151 0.129 CID_114981 | ||
| 0.23 | 0.037 | 0.23 | Tumour necrosis factor antagonist | 0.168 0.079 CID_114981 | ||
| 0.315 | 0.122 | 0.315 | MAP kinase kinase 6 inhibitor | |||
| 0.255 | 0.073 | 0.255 | Gastrin inhibitor | 0.202 0.146 CID_114981 | ||
| 0.198 | 0.023 | 0.198 | CF transmembrane conductance regulator agonist | |||
| 0.194 | 0.021 | 0.194 | Nav1.6 sodium channel blocker | |||
| 0.201 | 0.03 | 0.201 | Toll-Like receptor antagonist | |||
| 0.186 | 0.017 | 0.186 | Adenylate kinase inhibitor | 0.122 0.042 CID_114981 | ||
| 0.187 | 0.019 | 0.187 | Carbonic anhydrase III inhibitor | 0.129 0.038 CID_114981 | ||
| 0.18 | 0.012 | 0.18 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.195 | 0.028 | 0.195 | Alkylator | 0.177 0.034 CID_114981 | ||
| 0.2 | 0.034 | 0.2 | Nav1.2 sodium channel blocker | |||
| 0.174 | 0.009 | 0.174 | Toll-Like receptor 3 antagonist | |||
| 0.2 | 0.037 | 0.2 | Ribosomal protein S6 kinase inhibitor | |||
| 0.187 | 0.027 | 0.187 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.269 | 0.11 | 0.269 | Angiogenesis inhibitor | |||
| 0.177 | 0.019 | 0.177 | Photosensitizer | 0.123 0.053 CID_114981 | ||
| 0.197 | 0.04 | 0.245 | ATPase inhibitor | 0.245 0.015 CID_114981 | CID_114981 | |
| 0.192 | 0.036 | 0.192 | Hemostatic | |||
| 0.231 | 0.075 | 0.231 | Neuropeptide Y2 antagonist | |||
| 0.215 | 0.059 | 0.215 | CDC-like kinase 2 inhibitor | |||
| 0.169 | 0.013 | 0.169 | NMDA 2 receptor antagonist | |||
| 0.234 | 0.081 | 0.234 | Calpain inhibitor | |||
| 0.167 | 0.014 | 0.167 | NADH dehydrogenase inhibitor | 0.098 0.045 CID_114981 | ||
| 0.162 | 0.01 | 0.162 | Phenylalanine 4-hydroxylase inhibitor | 0.145 0.013 CID_114981 | ||
| 0.169 | 0.018 | 0.169 | DNA repair enzyme inhibitor | |||
| 0.279 | 0.128 | 0.279 | Calpain 2 inhibitor | |||
| 0.156 | 0.005 | 0.156 | CD45 antagonist | |||
| 0.291 | 0.142 | 0.291 | Antibacterial | |||
| 0.155 | 0.007 | 0.155 | GABA aminotransferase inhibitor | 0.076 0.052 CID_114981 | ||
| 0.171 | 0.023 | 0.171 | Interleukin 8 antagonist | |||
| 0.165 | 0.017 | 0.165 | Porphobilinogen synthase inhibitor | 0.081 0.047 CID_114981 | ||
| 0.263 | 0.116 | 0.263 | Cholesterol antagonist | |||
| 0.151 | 0.005 | 0.151 | D-Ala-D-Ala ligase inhibitor | 0.097 0.033 CID_114981 | ||
| 0.149 | 0.005 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.046 CID_114981 | ||
| 0.156 | 0.012 | 0.156 | Histamine N-methyltransferase inhibitor | |||
| 0.188 | 0.045 | 0.188 | Arachidonic acid antagonist | 0.127 0.117 CID_114981 | ||
| 0.161 | 0.019 | 0.161 | Carbonic anhydrase VI inhibitor | 0.074 0.065 CID_114981 | ||
| 0.192 | 0.05 | 0.192 | Phospholipase C inhibitor | |||
| 0.187 | 0.045 | 0.187 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.174 | 0.032 | 0.174 | Cathepsin H inhibitor | |||
| 0.163 | 0.023 | 0.163 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.101 CID_114981 | ||
| 0.159 | 0.02 | 0.159 | Creatine kinase inhibitor | 0.106 0.053 CID_114981 | ||
| 0.161 | 0.022 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.143 0.061 CID_114981 | ||
| 0.16 | 0.021 | 0.16 | NMDA receptor antagonist | 0.094 0.051 CID_114981 | ||
| 0.171 | 0.032 | 0.171 | MAP kinase kinase 4 inhibitor | |||
| 0.151 | 0.013 | 0.151 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.142 | 0.004 | 0.142 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.11 0.009 CID_114981 | ||
| 0.156 | 0.02 | 0.156 | Nitric-oxide synthase inhibitor | |||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | |||
| 0.17 | 0.035 | 0.17 | Adenylate cyclase stimulant | 0.139 0.084 CID_114981 | ||
| 0.16 | 0.026 | 0.16 | Protein kinase C gamma inhibitor | |||
| 0.159 | 0.026 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.146 0.03 CID_114981 | ||
| 0.152 | 0.02 | 0.152 | DOPA decarboxylase inhibitor | 0.101 0.073 CID_114981 | ||
| 0.142 | 0.011 | 0.142 | Alcohol oxidase inhibitor | 0.062 0.034 CID_114981 | ||
| 0.157 | 0.028 | 0.157 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.153 | 0.026 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 CID_114981 | ||
| 0.169 | 0.041 | 0.169 | Anesthetic local | |||
| 0.16 | 0.035 | 0.16 | Alpha 2b adrenoreceptor antagonist | |||
| 0.193 | 0.067 | 0.193 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.165 | 0.04 | 0.165 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.176 | 0.051 | 0.176 | Lck kinase inhibitor | |||
| 0.141 | 0.016 | 0.141 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.13 | 0.005 | 0.13 | Potassium channel (Ca-activated) blocker | |||
| 0.143 | 0.02 | 0.143 | Histidine decarboxylase inhibitor | |||
| 0.156 | 0.034 | 0.156 | Falcipain 3 inhibitor | |||
| 0.158 | 0.037 | 0.158 | MAP kinase 12 inhibitor | |||
| 0.138 | 0.017 | 0.138 | Interleukin 12 antagonist | |||
| 0.143 | 0.022 | 0.171 | Triose-phosphate isomerase inhibitor | 0.171 0.015 CID_114981 | CID_114981 | |
| 0.125 | 0.005 | 0.125 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.131 | 0.012 | 0.131 | Biliverdin reductase inhibitor | 0.061 0.04 CID_114981 | ||
| 0.14 | 0.021 | 0.14 | Pim-3 kinase inhibitor | |||
| 0.198 | 0.081 | 0.198 | Psychostimulant | |||
| 0.139 | 0.024 | 0.139 | Alcohol dehydrogenase inhibitor | |||
| 0.139 | 0.024 | 0.139 | TIE-2 antagonist | |||
| 0.192 | 0.078 | 0.192 | Non-steroidal antiinflammatory agent | 0.167 0.098 CID_114981 | ||
| 0.159 | 0.045 | 0.159 | Topoisomerase II inhibitor | |||
| 0.139 | 0.025 | 0.139 | TIE antagonist | |||
| 0.139 | 0.029 | 0.139 | Catalase inhibitor | |||
| 0.114 | 0.004 | 0.114 | Transcription factor RelA inhibitor | 0.063 0.045 CID_114981 | ||
| 0.185 | 0.077 | 0.185 | DNA methyltransferase I inhibitor | |||
| 0.165 | 0.058 | 0.165 | Thiol protease inhibitor | |||
| 0.132 | 0.026 | 0.132 | Carbonic anhydrase XIII inhibitor | |||
| 0.155 | 0.049 | 0.155 | MAP kinase kinase inhibitor | 0.144 0.055 CID_114981 | ||
| 0.162 | 0.059 | 0.162 | Protein kinase (CK1) inhibitor | |||
| 0.131 | 0.028 | 0.131 | Electrolyte absorption antagonist | |||
| 0.136 | 0.033 | 0.136 | Potassium channel (Ca-activated) activator | |||
| 0.134 | 0.032 | 0.159 | Sphingomyelinase inhibitor | 0.159 0.021 CID_114981 | CID_114981 | |
| 0.15 | 0.048 | 0.15 | Cyclooxygenase 3 inhibitor | |||
| 0.173 | 0.071 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.125 | 0.024 | 0.125 | CYP2A6 inhibitor | 0.066 0.065 CID_114981 | ||
| 0.128 | 0.029 | 0.128 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.148 | 0.049 | 0.148 | Aldehyde dehydrogenase inhibitor | |||
| 0.111 | 0.013 | 0.111 | CDC25B inhibitor | |||
| 0.111 | 0.013 | 0.111 | Purinergic P2X1 antagonist | |||
| 0.124 | 0.027 | 0.124 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.223 | 0.126 | 0.223 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.185 | 0.09 | 0.185 | Pyruvate kinase inhibitor | 0.14 0.125 CID_114981 | ||
| 0.108 | 0.014 | 0.108 | Carbonic anhydrase VB inhibitor | 0.049 0.046 CID_114981 | ||
| 0.107 | 0.013 | 0.107 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_114981 | ||
| 0.137 | 0.044 | 0.143 | Aminopeptidase B inhibitor | 0.143 0.041 CID_114981 | CID_114981 | |
| 0.105 | 0.012 | 0.105 | NMDA 2A receptor antagonist | |||
| 0.155 | 0.063 | 0.155 | Activin receptor-like kinase 2 inhibitor | |||
| 0.107 | 0.016 | 0.107 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.216 | 0.125 | 0.216 | Lipoxygenase inhibitor | 0.209 0.131 CID_114981 | ||
| 0.109 | 0.018 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.048 CID_114981 | ||
| 0.195 | 0.103 | 0.195 | Antiamyloidogenic | |||
| 0.163 | 0.073 | 0.163 | Neurotensin receptor agonist | |||
| 0.146 | 0.056 | 0.146 | Heat shock protein 70 antagonist | |||
| 0.116 | 0.026 | 0.116 | Phosphofructokinase-1 inhibitor | 0.069 0.048 CID_114981 | ||
| 0.232 | 0.142 | 0.232 | Vasodilator, peripheral | |||
| 0.1 | 0.011 | 0.1 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR6) antagonist | 0.064 0.053 CID_114981 | ||
| 0.181 | 0.092 | 0.181 | DNA methylase inhibitor | |||
| 0.095 | 0.007 | 0.095 | Calcium channel P-type blocker | |||
| 0.156 | 0.069 | 0.156 | Acetylcholine M1 receptor antagonist | |||
| 0.134 | 0.048 | 0.134 | Microtubule formation inhibitor | |||
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | |||
| 0.089 | 0.005 | 0.089 | Thymidylate synthase inhibitor | 0.069 0.012 CID_114981 | ||
| 0.112 | 0.028 | 0.112 | Inducible nitric-oxide synthase inhibitor | |||
| 0.119 | 0.036 | 0.119 | MAP kinase kinase 1 inhibitor | |||
| 0.15 | 0.067 | 0.191 | MAP kinase 3 inhibitor | 0.191 0.028 CID_114981 | CID_114981 | |
| 0.104 | 0.021 | 0.104 | T cell inhibitor | |||
| 0.109 | 0.027 | 0.109 | Glutamate dehydrogenase inhibitor | |||
| 0.086 | 0.004 | 0.086 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_114981 | ||
| 0.087 | 0.006 | 0.087 | Alpha 1b adrenoreceptor agonist | |||
| 0.098 | 0.018 | 0.098 | NMDA receptor glycine site agonist | 0.079 0.029 CID_114981 | ||
| 0.111 | 0.031 | 0.111 | I kappa B kinase inhibitor | |||
| 0.149 | 0.07 | 0.149 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.104 | 0.025 | 0.104 | Caspase 7 inhibitor | |||
| 0.119 | 0.04 | 0.119 | Anabolic | |||
| 0.092 | 0.013 | 0.092 | Exportin-1 inhibitor | |||
| 0.132 | 0.054 | 0.132 | Protein kinase (CK2) alpha inhibitor | |||
| 0.093 | 0.015 | 0.093 | I kappa B kinase 2 inhibitor | |||
| 0.106 | 0.029 | 0.106 | Myeloperoxidase inhibitor | |||
| 0.096 | 0.02 | 0.096 | Argininosuccinate synthase inhibitor | |||
| 0.093 | 0.018 | 0.093 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.087 | 0.011 | 0.087 | Aconitate hydratase inhibitor | 0.059 0.027 CID_114981 | ||
| 0.082 | 0.007 | 0.082 | AICAR transformylase inhibitor | |||
| 0.138 | 0.064 | 0.138 | NADPH oxidase inhibitor | |||
| 0.079 | 0.005 | 0.079 | Dihydrofolate reductase inhibitor | |||
| 0.132 | 0.058 | 0.132 | Adenylate cyclase inhibitor | |||
| 0.142 | 0.068 | 0.142 | Amylase inhibitor | |||
| 0.122 | 0.049 | 0.122 | MAP kinase 9 inhibitor | |||
| 0.121 | 0.048 | 0.121 | Nav1.1 sodium channel blocker | |||
| 0.099 | 0.026 | 0.099 | Estrogen-related receptor beta agonist | |||
| 0.127 | 0.055 | 0.127 | Calcium channel N-type blocker | |||
| 0.093 | 0.02 | 0.093 | MAP kinase kinase 7 inhibitor | |||
| 0.133 | 0.061 | 0.133 | CC chemokine 6 receptor antagonist | |||
| 0.094 | 0.022 | 0.094 | GABA B receptor agonist | 0.075 0.052 CID_114981 | ||
| 0.116 | 0.045 | 0.116 | Pim-1 kinase inhibitor | |||
| 0.099 | 0.028 | 0.099 | Alpha adrenoreceptor agonist | |||
| 0.097 | 0.026 | 0.097 | Carbonic anhydrase VA inhibitor | |||
| 0.1 | 0.03 | 0.109 | Glutamate decarboxylase inhibitor | 0.109 0.025 CID_114981 | CID_114981 | |
| 0.085 | 0.015 | 0.085 | AMPA receptor antagonist | 0.068 0.022 CID_114981 | ||
| 0.12 | 0.05 | 0.12 | Alpha 2c adrenoreceptor antagonist | |||
| 0.111 | 0.041 | 0.111 | Potassium channel (Voltage-sensitive) activator | |||
| 0.117 | 0.048 | 0.128 | Urease inhibitor | 0.128 0.038 CID_114981 | CID_114981 | |
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.182 | 0.113 | 0.182 | ErbB-1 antagonist | |||
| 0.116 | 0.048 | 0.116 | CDC-like kinase 3 inhibitor | |||
| 0.093 | 0.026 | 0.093 | Glycine receptor agonist | |||
| 0.087 | 0.02 | 0.087 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.143 | 0.076 | 0.143 | Neuropeptide Y1 antagonist | |||
| 0.095 | 0.029 | 0.095 | Carbonic anhydrase V inhibitor | |||
| 0.109 | 0.044 | 0.109 | Glutamate (mGluR7) agonist | |||
| 0.07 | 0.005 | 0.07 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 CID_114981 | ||
| 0.152 | 0.087 | 0.152 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.097 | 0.032 | 0.097 | Purinergic P2X2 antagonist | |||
| 0.119 | 0.054 | 0.119 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.078 | 0.014 | 0.078 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | 0.072 0.009 CID_114981 | ||
| 0.173 | 0.109 | 0.173 | Angiogenesis stimulant | |||
| 0.102 | 0.038 | 0.102 | Topoisomerase II alpha inhibitor | |||
| 0.084 | 0.021 | 0.084 | Alpha 2 adrenoreceptor agonist | |||
| 0.126 | 0.064 | 0.126 | DNA polymerase I inhibitor | |||
| 0.071 | 0.008 | 0.071 | Dopamine D5 agonist | 0.037 0.033 CID_114981 | ||
| 0.105 | 0.043 | 0.105 | Thioredoxin inhibitor | |||
| 0.087 | 0.025 | 0.087 | Phospholipase D inhibitor | |||
| 0.085 | 0.024 | 0.085 | 5 Hydroxytryptamine 3 agonist | |||
| 0.086 | 0.025 | 0.086 | NMDA receptor agonist | 0.063 0.043 CID_114981 | ||
| 0.078 | 0.018 | 0.078 | Botulinum neurotoxin type A inhibitor | 0.064 0.032 CID_114981 | ||
| 0.073 | 0.013 | 0.073 | NMDA receptor subunit 3A antagonist | |||
| 0.084 | 0.024 | 0.084 | Protein kinase C beta inhibitor | |||
| 0.086 | 0.026 | 0.097 | Histone deacetylase inhibitor | 0.097 0.019 CID_114981 | CID_114981 | |
| 0.108 | 0.048 | 0.108 | Prolactin inhibitor | |||
| 0.117 | 0.058 | 0.117 | Topoisomerase I inhibitor | |||
| 0.068 | 0.009 | 0.068 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.074 | 0.015 | 0.074 | Epithelial sodium channel blocker | |||
| 0.129 | 0.071 | 0.129 | Acetylcholinesterase inhibitor | |||
| 0.065 | 0.007 | 0.065 | Nerve growth factor antagonist | |||
| 0.075 | 0.018 | 0.075 | Carbonic anhydrase XIV inhibitor | |||
| 0.07 | 0.013 | 0.07 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.087 | 0.03 | 0.087 | I kappa B kinase 1 inhibitor | |||
| 0.122 | 0.066 | 0.122 | TRKA antagonist | |||
| 0.078 | 0.021 | 0.078 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.071 | 0.015 | 0.071 | NMDA receptor subunit 3B antagonist | |||
| 0.118 | 0.063 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.046 CID_114981 | CID_114981 | |
| 0.153 | 0.099 | 0.153 | TRKC antagonist | |||
| 0.129 | 0.075 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.061 | 0.007 | 0.061 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.068 | 0.014 | 0.068 | Sodium/calcium exchanger inhibitor | |||
| 0.088 | 0.035 | 0.088 | Aminopeptidase I inhibitor | |||
| 0.109 | 0.056 | 0.109 | Protein kinase (CK2) inhibitor | |||
| 0.056 | 0.004 | 0.056 | Alpha 2a adrenoreceptor agonist | 0.023 0.008 CID_114981 | ||
| 0.091 | 0.039 | 0.091 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | |||
| 0.141 | 0.09 | 0.141 | Src kinase inhibitor | |||
| 0.062 | 0.011 | 0.062 | Dihydropteroate synthase inhibitor | |||
| 0.161 | 0.111 | 0.161 | MAP kinase kinase 5 inhibitor | |||
| 0.065 | 0.015 | 0.065 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.129 | 0.079 | 0.129 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.093 | 0.043 | 0.093 | Histamine H2 receptor antagonist | |||
| 0.068 | 0.019 | 0.068 | Dihydroorotate oxidase inhibitor | 0.065 0.022 CID_114981 | ||
| 0.181 | 0.132 | 0.234 | Immunostimulant | 0.234 0.103 CID_114981 | CID_114981 | |
| 0.123 | 0.075 | 0.123 | Toll-Like receptor 2 antagonist | |||
| 0.118 | 0.07 | 0.118 | Beta amyloid protein antagonist | |||
| 0.066 | 0.018 | 0.066 | Topoisomerase II beta inhibitor | |||
| 0.089 | 0.042 | 0.089 | Alpha 2a adrenoreceptor antagonist | |||
| 0.087 | 0.04 | 0.087 | Rho-associated kinase I inhibitor | |||
| 0.059 | 0.012 | 0.059 | GABA B receptor antagonist | |||
| 0.158 | 0.112 | 0.158 | Interleukin antagonist | |||
| 0.107 | 0.061 | 0.124 | Mediator release inhibitor | 0.124 0.044 CID_114981 | CID_114981 | |
| 0.081 | 0.036 | 0.081 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.119 | 0.075 | 0.119 | Glutamate receptor antagonist | |||
| 0.087 | 0.043 | 0.087 | Interferon agonist | |||
| 0.139 | 0.095 | 0.139 | Interferon gamma antagonist | |||
| 0.067 | 0.023 | 0.067 | Ryanodine receptor antagonist | 0.059 0.042 CID_114981 | ||
| 0.067 | 0.024 | 0.067 | Sphingosine kinase 2 inhibitor | |||
| 0.068 | 0.025 | 0.068 | Kallikrein 1 inhibitor | |||
| 0.061 | 0.017 | 0.061 | Adenylate cyclase 1 inhibitor | 0.043 0.038 CID_114981 | ||
| 0.24 | 0.198 | 0.24 | DNA directed DNA polymerase inhibitor | |||
| 0.109 | 0.066 | 0.109 | Mucolytic | |||
| 0.052 | 0.01 | 0.052 | Potassium channel small-conductance Ca-activated activator | |||
| 0.113 | 0.071 | 0.113 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.12 | 0.078 | 0.136 | M17 leucyl aminopeptidase inhibitor | 0.136 0.065 CID_114981 | CID_114981 | |
| 0.133 | 0.091 | 0.133 | Diuretic | |||
| 0.124 | 0.083 | 0.124 | Tyrosine-protein kinase receptor antagonist | |||
| 0.067 | 0.026 | 0.067 | Pim-2 kinase inhibitor | |||
| 0.1 | 0.06 | 0.1 | MAP kinase 8 inhibitor | |||
| 0.057 | 0.016 | 0.057 | Cytokine production stimulant | |||
| 0.122 | 0.082 | 0.122 | Sodium channel blocker | |||
| 0.058 | 0.017 | 0.058 | Kainate receptor antagonist | 0.052 0.02 CID_114981 | ||
| 0.06 | 0.02 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 CID_114981 | CID_114981 | |
| 0.067 | 0.028 | 0.067 | Prolactin release inhibitor | |||
| 0.061 | 0.022 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.071 | 0.032 | 0.071 | Carbonic anhydrase IX inhibitor | |||
| 0.091 | 0.053 | 0.091 | Bromodomain-containing protein 2 inhibitor | |||
| 0.068 | 0.031 | 0.068 | Histone deacetylase SIRT3 inhibitor | |||
| 0.077 | 0.04 | 0.077 | Secretase beta inhibitor | |||
| 0.052 | 0.015 | 0.052 | Histamine H1 receptor agonist | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | |||
| 0.056 | 0.019 | 0.056 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.123 | 0.086 | 0.123 | Protein kinase (CK1) gamma inhibitor | |||
| 0.055 | 0.018 | 0.055 | Histamine H2 receptor agonist | |||
| 0.04 | 0.004 | 0.04 | Complement factor 1s inhibitor | |||
| 0.115 | 0.079 | 0.115 | Nav1.3 sodium channel blocker | |||
| 0.05 | 0.014 | 0.05 | Diamine oxidase inhibitor | |||
| 0.131 | 0.096 | 0.131 | NOS3 expression enhancer | |||
| 0.085 | 0.05 | 0.085 | Glycine receptor antagonist | |||
| 0.061 | 0.026 | 0.061 | Alpha-mannosidase inhibitor | 0.051 0.041 CID_114981 | ||
| 0.059 | 0.025 | 0.059 | Potassium channel (Inward rectifier) blocker | |||
| 0.084 | 0.05 | 0.084 | CC chemokine 5 receptor agonist | |||
| 0.061 | 0.027 | 0.061 | Lysine-specific demethylase 1A inhibitor | |||
| 0.09 | 0.056 | 0.09 | Ornithine decarboxylase inhibitor | |||
| 0.069 | 0.036 | 0.069 | Interferon inducer | |||
| 0.125 | 0.092 | 0.125 | Cell wall synthesis inhibitor | |||
| 0.062 | 0.029 | 0.062 | Glucosylceramidase inhibitor | |||
| 0.056 | 0.023 | 0.056 | Histamine H4 receptor antagonist | |||
| 0.055 | 0.023 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.015 CID_114981 | CID_114981 | |
| 0.089 | 0.057 | 0.089 | Alpha 2 adrenoreceptor antagonist | |||
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.043 | 0.011 | 0.043 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.089 | 0.058 | 0.089 | ATPase (Vacuolar H+) inhibitor | |||
| 0.065 | 0.035 | 0.065 | Cyclin D1 inhibitor | |||
| 0.042 | 0.012 | 0.042 | Cyclin E2 inhibitor | |||
| 0.07 | 0.04 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.111 | 0.081 | 0.111 | Protein kinase (CK1) delta inhibitor | |||
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | |||
| 0.049 | 0.02 | 0.049 | Histone deacetylase class I inhibitor | |||
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.109 | 0.08 | 0.109 | Acetylcholine muscarinic antagonist | |||
| 0.23 | 0.201 | 0.23 | Transcription factor inhibitor | |||
| 0.046 | 0.018 | 0.046 | Kainate receptor agonist | 0.039 0.036 CID_114981 | ||
| 0.059 | 0.032 | 0.059 | Ornithine carbamoyltransferase inhibitor | |||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | 0.032 0.014 CID_114981 | ||
| 0.069 | 0.042 | 0.069 | MAP kinase kinase 10 inhibitor | |||
| 0.042 | 0.015 | 0.042 | Purinergic P2Y2 antagonist | |||
| 0.09 | 0.063 | 0.09 | Protein kinase C delta inhibitor | |||
| 0.075 | 0.049 | 0.075 | CDC25A inhibitor | |||
| 0.059 | 0.033 | 0.059 | Carbonic anhydrase XII inhibitor | |||
| 0.062 | 0.036 | 0.062 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.063 | 0.037 | 0.063 | Carbonic anhydrase stimulant | |||
| 0.05 | 0.025 | 0.05 | Mannosidase inhibitor | |||
| 0.055 | 0.03 | 0.055 | Urokinase inhibitor | |||
| 0.061 | 0.036 | 0.061 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.062 | 0.038 | 0.062 | Adenosine A1 receptor antagonist | |||
| 0.119 | 0.094 | 0.122 | Protein kinase stimulant | 0.122 0.09 CID_114981 | CID_114981 | |
| 0.092 | 0.068 | 0.092 | Bile acid receptor antagonist | |||
| 0.128 | 0.104 | 0.128 | Pregnane X receptor agonist | |||
| 0.17 | 0.145 | 0.17 | Spasmolytic | |||
| 0.048 | 0.025 | 0.048 | Geranyltranstransferase inhibitor | |||
| 0.075 | 0.051 | 0.075 | Adenosine A3 receptor antagonist | |||
| 0.094 | 0.07 | 0.094 | Check point kinase 2 inhibitor | |||
| 0.047 | 0.024 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.063 | 0.04 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.037 | 0.015 | 0.037 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.08 | 0.058 | 0.08 | Adrenaline agonist | |||
| 0.041 | 0.018 | 0.041 | Fumarate hydratase inhibitor | |||
| 0.074 | 0.051 | 0.074 | Rho-associated kinase II inhibitor | |||
| 0.228 | 0.206 | 0.228 | DNA polymerase beta inhibitor | |||
| 0.138 | 0.116 | 0.138 | Amyloid beta precursor protein antagonist | |||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR4) antagonist | 0.042 0.033 CID_114981 | ||
| 0.027 | 0.005 | 0.027 | Alpha 2c adrenoreceptor agonist | |||
| 0.062 | 0.041 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.06 | 0.039 | 0.06 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | |||
| 0.055 | 0.035 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.029 | 0.008 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.173 | 0.152 | 0.173 | Streptokinase A inhibitor | |||
| 0.059 | 0.038 | 0.059 | Alpha 1 adrenoreceptor agonist | |||
| 0.044 | 0.024 | 0.044 | Thymidine kinase inhibitor | |||
| 0.064 | 0.044 | 0.064 | Carbonic anhydrase inhibitor | |||
| 0.115 | 0.095 | 0.115 | Cytokine production inhibitor | |||
| 0.04 | 0.021 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.041 | 0.021 | 0.041 | Potassium channel Kv1.1 blocker | |||
| 0.04 | 0.021 | 0.04 | Integrin alpha2 antagonist | |||
| 0.11 | 0.091 | 0.11 | Tubulin antagonist | |||
| 0.062 | 0.043 | 0.062 | Phosphodiesterase 1C inhibitor | 0.058 0.055 CID_114981 | ||
| 0.06 | 0.041 | 0.06 | Androgen agonist | |||
| 0.08 | 0.062 | 0.08 | Thioredoxin reductase inhibitor | |||
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.074 | 0.056 | 0.074 | Na+ K+ transporting ATPase inhibitor | |||
| 0.044 | 0.026 | 0.044 | Heme oxygenase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Dopamine autoreceptor agonist | |||
| 0.066 | 0.049 | 0.066 | MDM2 inhibitor | |||
| 0.041 | 0.024 | 0.041 | AMPA 4 receptor antagonist | |||
| 0.15 | 0.133 | 0.15 | Insulin sensitizer | |||
| 0.101 | 0.084 | 0.101 | Nav1.5 sodium channel blocker | |||
| 0.119 | 0.102 | 0.119 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.035 | 0.018 | 0.035 | Estrogen-related receptor beta antagonist | |||
| 0.04 | 0.023 | 0.058 | Histone deacetylase 7 inhibitor | 0.058 0.016 CID_114981 | CID_114981 | |
| 0.093 | 0.077 | 0.093 | Expectorant | |||
| 0.023 | 0.007 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.027 | 0.011 | 0.027 | 5 Hydroxytryptamine 4 agonist | |||
| 0.148 | 0.132 | 0.148 | Anticonvulsant | |||
| 0.029 | 0.013 | 0.029 | Integrin alpha2beta1 antagonist | |||
| 0.084 | 0.069 | 0.084 | Potassium channel activator | |||
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.03 | 0.015 | 0.03 | Estrogen-related receptor gamma antagonist | |||
| 0.031 | 0.016 | 0.031 | CDK4/cyclin D3 inhibitor | |||
| 0.031 | 0.016 | 0.031 | 5 Hydroxytryptamine 6 agonist | |||
| 0.058 | 0.043 | 0.058 | Sphingosine kinase inhibitor | |||
| 0.025 | 0.011 | 0.025 | CC chemokine 8 receptor antagonist | |||
| 0.026 | 0.012 | 0.026 | Glutamate (mGluR1a) agonist | |||
| 0.026 | 0.012 | 0.026 | Adenosine kinase inhibitor | |||
| 0.058 | 0.045 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.044 CID_114981 | CID_114981 | |
| 0.1 | 0.087 | 0.1 | TRPA1 agonist | |||
| 0.035 | 0.022 | 0.183 | Histone deacetylase 2 inhibitor | 0.183 0.007 CID_114981 | CID_114981 | |
| 0.033 | 0.02 | 0.033 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.059 | 0.046 | 0.059 | Adenosine A2a receptor antagonist | |||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase II inhibitor | |||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase I inhibitor | |||
| 0.093 | 0.081 | 0.093 | Beta glucuronidase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Hedgehog signaling activator | |||
| 0.028 | 0.016 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.11 | 0.099 | 0.11 | Calcium channel blocker | |||
| 0.046 | 0.035 | 0.046 | Aldosterone antagonist | |||
| 0.027 | 0.016 | 0.17 | Histone deacetylase 1 inhibitor | 0.17 0.006 CID_114981 | CID_114981 | |
| 0.072 | 0.061 | 0.072 | Keratolytic | |||
| 0.025 | 0.014 | 0.025 | Alpha 1a adrenoreceptor agonist | |||
| 0.037 | 0.026 | 0.037 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.035 | 0.024 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.039 | 0.028 | 0.045 | Histone deacetylase 9 inhibitor | 0.045 0.019 CID_114981 | CID_114981 | |
| 0.148 | 0.137 | 0.148 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.064 | 0.054 | 0.064 | Protein kinase C alpha inhibitor | |||
| 0.088 | 0.078 | 0.088 | MAP kinase kinase kinase inhibitor | |||
| 0.049 | 0.039 | 0.049 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.022 | 0.012 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.071 | 0.061 | 0.071 | Vanilloid 4 agonist | |||
| 0.03 | 0.02 | 0.03 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.044 | 0.035 | 0.044 | Purinergic P2X4 antagonist | |||
| 0.055 | 0.046 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.027 | 0.019 | 0.027 | Glucosylceramidase stimulant | |||
| 0.051 | 0.043 | 0.051 | Heparanase inhibitor | |||
| 0.017 | 0.009 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.061 | 0.053 | 0.061 | Beta 3 adrenoreceptor antagonist | |||
| 0.048 | 0.041 | 0.048 | Potassium channel (Inward rectifier) activator | |||
| 0.019 | 0.012 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.025 | 0.019 | 0.025 | Acid ceramidase inhibitor | |||
| 0.042 | 0.036 | 0.042 | Dihydroorotase inhibitor | |||
| 0.045 | 0.04 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.022 | 0.016 | 0.022 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.127 | 0.121 | 0.127 | Melanin inhibitor | |||
| 0.037 | 0.031 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.031 | 0.026 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.018 | 0.013 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.037 | 0.032 | 0.052 | Histone deacetylase 8 inhibitor | 0.052 0.02 CID_114981 | CID_114981 | |
| 0.084 | 0.079 | 0.084 | Phosphodiesterase 7B inhibitor | |||
| 0.039 | 0.034 | 0.039 | Guanylate cyclase inhibitor | |||
| 0.052 | 0.047 | 0.052 | MAP kinase kinase 9 inhibitor | |||
| 0.02 | 0.016 | 0.02 | Factor XIII inhibitor | |||
| 0.025 | 0.021 | 0.025 | Complement factor 1r inhibitor | |||
| 0.095 | 0.091 | 0.095 | Calcium channel (voltage-sensitive) blocker | |||
| 0.083 | 0.079 | 0.083 | Butyrylcholinesterase inhibitor | |||
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.017 | 0.013 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.039 | 0.035 | 0.039 | Glutamate (mGluR group III) agonist | |||
| 0.059 | 0.055 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.026 | 0.023 | 0.026 | Liver X receptor beta antagonist | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.051 | 0.048 | 0.051 | Aromatase inhibitor | |||
| 0.025 | 0.022 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.059 | 0.056 | 0.059 | Aryl hydrocarbon receptor antagonist | |||
| 0.07 | 0.068 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.065 CID_114981 | CID_114981 | |
| 0.071 | 0.07 | 0.071 | Protein kinase A inhibitor | |||
| 0.031 | 0.03 | 0.031 | Glutamate (mGluR4) agonist | |||
| 0.099 | 0.098 | 0.099 | Cholinergic antagonist | |||
| 0.029 | 0.028 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.031 | 0.03 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.055 | 0.054 | 0.055 | Adenosine A2 receptor antagonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.011 | 0.012 | 0.052 | Human herpes virus 5 capsid protein P40 inhibitor | 0.052 0.003 CID_114981 | CID_114981 | |
| 0.018 | 0.023 | 0.083 | Histone deacetylase 3 inhibitor | 0.083 0.008 CID_114981 | CID_114981 | |
| 0.01 | 0.017 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 CID_114981 | CID_114981 | |
| 0.018 | 0.052 | 0.09 | Histone deacetylase class IV inhibitor | 0.09 0.006 CID_114981 | CID_114981 | |
| 0.018 | 0.052 | 0.09 | Histone deacetylase 11 inhibitor | 0.09 0.006 CID_114981 | CID_114981 | |
| 0.036 | 0.071 | 0.096 | Aminopeptidase microsomal inhibitor | 0.096 0.018 CID_114981 | CID_114981 | |
| 0.027 | 0.07 | 0.037 | Acid-sensing ion channel blocker | 0.037 0.034 CID_114981 | CID_114981 | |
| 0.025 | 0.068 | 0.079 | Aminopeptidase N inhibitor | 0.079 0.018 CID_114981 | CID_114981 | |
| 0.01 | 0.072 | 0.074 | Histone deacetylase 10 inhibitor | 0.074 0.007 CID_114981 | CID_114981 | |
| 0.01 | 0.076 | 0.152 | Histone deacetylase 5 inhibitor | 0.152 0.006 CID_114981 | CID_114981 | |
| 0.044 | 0.136 | 0.07 | Metalloproteinase-2 inhibitor | 0.07 0.066 CID_114981 | CID_114981 | |
| 0.115 | 0.214 | 0.179 | Death-associated protein kinase 2 inhibitor | 0.179 0.055 CID_114981 | CID_114981 | |
| 0.009 | 0.109 | 0.121 | Histone deacetylase class IIa inhibitor | 0.121 0.007 CID_114981 | CID_114981 | |
| 0.018 | 0.149 | 0.067 | Collagenase inhibitor | 0.067 0.011 CID_114981 | CID_114981 | |
| 0.008 | 0.169 | 0.151 | Histone deacetylase class II inhibitor | 0.151 0.006 CID_114981 | CID_114981 | |
| 0.034 | 0.224 | 0.22 | 5-Lipoxygenase inhibitor | 0.22 0.021 CID_114981 | CID_114981 | |
| 0.007 | 0.236 | 0.066 | Histone deacetylase 4 inhibitor | 0.066 0.009 CID_114981 | CID_114981 | |
| 0.005 | 0.299 | 0.14 | Histone deacetylase class IIb inhibitor | 0.14 0.006 CID_114981 | CID_114981 | |
| 0.005 | 0.307 | 0.139 | Histone deacetylase 6 inhibitor | 0.139 0.006 CID_114981 | CID_114981 | |
| 0.006 | 0.42 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 CID_114981 | CID_114981 | |
| 0.011 | 0.525 | 0.054 | ADAM10 endopeptidase inhibitor | 0.054 0.008 CID_114981 | CID_114981 | |
| 0.009 | 0.737 | 0.038 | Aggrecanase 1 inhibitor | 0.038 0.03 CID_114981 | CID_114981 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |